Your browser doesn't support javascript.
loading
Dissection of the potential anti-influenza materials and mechanism of Lonicerae japonicae flos based on in vivo substances profiling and network pharmacology.
Zhang, Feng-Xiang; Li, Zi-Ting; Li, Min; Yuan, Yu-Lin-Lan; Cui, Shuang-Shuang; Chen, Jia-Xu; Li, Rui-Man.
Afiliação
  • Zhang FX; Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China; Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, Guangdong, China.
  • Li ZT; Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Li M; Hainan Trauma and Disaster Rescue Key Laboratory, The First Affiliated Hospital of Hainan Medical College, Haikou 571199, China.
  • Yuan YL; Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China.
  • Cui SS; Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China.
  • Chen JX; Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, Guangdong, China. Electronic address: chenjiaxu@hotmail.com.
  • Li RM; Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China. Electronic address: hqyylrm@126.com.
J Pharm Biomed Anal ; 193: 113721, 2021 Jan 30.
Article em En | MEDLINE | ID: mdl-33147537
ABSTRACT
Lonicerae japonicae flos.(LJF) was widely used as a drug to treat upper respiratory tract infection or a tea to clear heat in Asian countries for thousands of years. Despite of its curative effects confirmed by modern pharmacological methods, its functional materials and mechanism against influenza were still unclear and needed further investigation. In this study, an integrated strategy based on in vivo substances profiling and network pharmacology was proposed and applied to screen out the potential anti-influenza substances and mechanism of LJF. An UHPLC/Q-TOF MS method was utilized to profile the chemical components in LJF and their metabolites in rats. The targets of absorbed prototypes were predicted by Swiss Target Prediction, and they were further analyzed by String and Kyoto Encyclopedia of Genes and Genomes (KEGG). As a result, a total of 126 chemical components mainly featuring three chemical structure types were characterized, including 70 iridoid glycosides, 17 caffeoylquinic acids, 24 flavonoids, and 15 other types compounds. Among them, ten N-contained iridoid glycosides were characterized as potential novel compounds. Moreover, 141 xenobiotics (74 prototypes and 67 metabolites) were clearly screened out in rat plasma and urine after ingestion of LJF. Phase II reactions (sulfation, glucuronidation, methylation) and phase I reactions (dehydroxylation, hydrogenation, hydrolysis, N-heterocyclization) were the main metabolic reactions of LJF in rats. Further, a total of 338 targets were predicted and TNF, PTGS2 and EGFR were the three main targets involved in the pathology of influenza. In addition to normal NF-κB pathway, T cell signal pathway and mTOR signal pathway were the other patterns for LJF to achieve its anti-flu effects. Our work provided the meaningful data for further pharmacological validation of LJF against influenza, and a new strategy was also proposed for minimizing the process to reveal the mechanism and functional basis of TCMs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Lonicera / Influenza Humana Limite: Animals Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Lonicera / Influenza Humana Limite: Animals Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China